Forbes, B.; Goodacre, L.; Lansley, A.B.; Martin, A.R.; Palmer, H.; Patterson, C.; Roe, C.; Scherließ, R. Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics 2025, 17, 1321. https://doi.org/10.3390/pharmaceutics17101321

AMA Style

Forbes B, Goodacre L, Lansley AB, Martin AR, Palmer H, Patterson C, Roe C, Scherließ R. Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics. 2025; 17(10):1321. https://doi.org/10.3390/pharmaceutics17101321

Chicago/Turabian Style

Forbes, Ben, Lucy Goodacre, Alison B. Lansley, Andrew R. Martin, Helen Palmer, Claire Patterson, Chris Roe, and Regina Scherließ. 2025. "Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs" Pharmaceutics 17, no. 10: 1321. https://doi.org/10.3390/pharmaceutics17101321

APA Style

Forbes, B., Goodacre, L., Lansley, A. B., Martin, A. R., Palmer, H., Patterson, C., Roe, C., & Scherließ, R. (2025). Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics, 17(10), 1321. https://doi.org/10.3390/pharmaceutics17101321

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI